Make it viral.

Oncologists should support - not oppose - Medicare drug price negotiation. Lower drug prices benefit patients; this should supersede revenue concerns. So @dusetzinas.bsky.social @rachelsachs.bsky.social and I argue today in @jamaoncology.com jamanetwork.com/journals/jam... 1/

Oncologists should support - not oppose - Medicare drug price negotiation. Lower drug prices benefit patients; this should supersede revenue concerns. So @dusetzinas.bsky.social @rachelsachs.bsky.social and I argue today in @jamaoncology.com jamanetwork.com/journals/jam... 1/

Y’all I just dug these out of an attic where they have been for the last THIRTY YEARS and they STILL WORK!

The linked study cites an article which lists me as an author, but which does not actually exist. I complained to the journal editors. Over a year later, the study is still there, no retractions or corrections. pubmed.ncbi.nlm.nih.gov/39614949/

“Over the past few years, the group has found that hospitals are a hotspot for outsized markups of all kinds. In one case, the plan paid almost $90,000 for a series of oxaliplatin infusions…that’s more than 700 times what Medicare would’ve paid at the time.”

This entire “Cancer Capitalism” series from @bloomberg.com is worth a read! Latest topic: the astronomical markups that hospitals charge on cancer drugs: www.bloomberg.com/features/202...

Very cool!

reality has an unfair anti-Trump bias

Anti-vaxxism is an ideology with maybe the dumbest combination of pointless and evil that has ever existed bsky.app/profile/nyti...

lol this month’s issue of JCO appears to have been resected with positive margins

"One agency source said at least one division is having to pour all of its resources into reviewing drugs that received a voucher, taking time away from other medical products."

I didn’t really get how much “health care contact days” is a meaningful patient outcome until I got sick thank you @ishaniganguli.bsky.social @dusetzinas.bsky.social @jamanetworkopen.com

So, to all the "RFK's got some good ideas" folks (Rachael Bedard, Leana Wen) and Jay Bhattacharya is "an excellent choice for NIH" (Steven Macedo, Frances Lee) and Vinay Prasad "will bring a breath of fresh air to FDA" (Adam Cifu, John Mandrola) groupies--you own this now too.

Government documents obtained by @kffhealthnews.org show the agency overseeing Medicare Advantage does little to enforce long-standing rules intended to ensure about 35 million plan members can see doctors in the first place.

@medscape.com piece on biosimilars policy, including our recent @jamanetworkopen.com study on biosimilar prices: www.medscape.com/viewarticle/...

In good company alongside some cutting-edge basic science, our recent @bmj.com study examining the association between cancer drug profitability and utilization made the @mskcancercenter.bsky.social research highlights! www.mskcc.org/news/msk-res... @dusetzinas.bsky.social

It had been far too long since my last GREETINGS OF THE DAY email! This one may be my new all time favorite. How much better could you signal "this is spam"? LOL right now 🤣 @ankurfactorial.bsky.social

When someone leaves the “-ized” out of “generalized estimating equations”

NEW: We’ve uncovered the first known example of taxpayer money flowing from DHS to businesses controlled by Kristi Noem’s allies and friends. It’s part of a money trail that’s been shrouded in secrecy—and involves $220 million, a mysterious Delaware LLC & a horse named Gill.

KIDS. Every morning, how does it always take 20 minutes between “ready to leave” and “ready to leave”????

“Housing shortage – Jews to blame," letter sticker, German Reich, 1938 zwangsraeume.berlin/en/context

NIH program officer @jenna-m-norton.bsky.social has been placed on admin leave, sources say. Norton has been outspoken about the Trump administration's dismantling of science, and she signed the Bethesda Declaration. Bhattacharya has said that "science is dead without free speech".

Honored to have been a co-author on you first thread in this role! But the credit is really all to Dr. Paul, who led this study. I was honored to have been asked to collaborate by the @portalresearch.org team

Excited to see this study out in the world! Looks at the counterfactual of a world in which biosimilars didn't launch. Always fun working with @thewonkologist.bsky.social

Our new study is out today in @jamanetworkopen.com! We looked at trends in biologic drug prices after biosimilar competition. Key takeaways: savings from biosimilars are substantial, but take longer to accrue than commonly seen with generic small molecules. 1/ jamanetwork.com/journals/jam...

As the ~discourse~ seems to bend interminably towards Republicans trying to figure out how they can (further) HDHP-ify ACA coverage, it's worth revisiting what is probably our best (most rigorous) study on the effect of deductibles in health insurance. academic.oup.com/qje/article-...

Postdoc opportunity at @mskcancercenter.bsky.social ! Read about and apply to OPTICS below:

Cool. What would you call the other wing then? www.nytimes.com/2025/11/03/u...

This study could be titled "what makes doctors quit" The answers are saddening: 1) being a woman 2) practicing in a rural area 3) caring for sicker patients and dual-eligible patients www.acpjournals.org/doi/10.7326/...

Our new study, out yesterday in @bmj.com ! 👇🏼👇🏼👇🏼

Our new study is published today in @bmj.com! We studied whether oncologists tend to use cancer treatments that are more beneficial, more profitable, or both. I was surprised by the results: clinical benefit mattered, profit did not. 1/ cc: @dusetzinas.bsky.social www.bmj.com/content/391/...

3 year old: “I want to be a firefighter and not a doctor because I want to save people” Ouch

Important new analysis from @matthewherper.bsky.social and @lizzylawrence.bsky.social about the ongoing situation at FDA. This quote from an agency staffer sums up the potential concerns. www.statnews.com/2025/11/04/f...

These quoted phrases are precisely what we knew an agency with Vinay Prasad in leadership would look like.

💊 Prescription drug prices have long risen faster than inflation, straining budgets for patients and the government alike. A new Medicare policy aims to slow that trend, and it could save billions over the next decade. Explore the details in our new explainer:

Love to see an implementation win in @ascocancer.bsky.social/ #JCOOP ⬇️ In a mix of community/academic practices in NE, low overall inappropriate use of denosumab/zolendronic acid for mHSPC compared to prior national studies. ascopubs.org/doi/10.1200/...

Our new study is out today in JCO Oncology Practice @ascocancer.bsky.social! We studied the use of guideline-concordant bone agents for prostate cancer, and found a large degree of inter-provider variation... 1/ ascopubs.org/doi/10.1200/...

"None of the proposals outlined by Makary and Prasad justify firing hundreds of scientific experts dedicated to protecting public health. Staffing and budget cuts will only further diminish the FDA’s capacity to approve drugs in a timely manner." jamanetwork.com/journals/jam... True words

I got my Covid and flu booster shots recently The evidence supporting this is extensive 👇🏾 www.nejm.org/doi/full/10....

This is the first @nytimes.com food list I’ve seen that I’ve actually tried most of! We especially love the PDQs at Padoca bakery, Petee’s Pie, the fan tuan at Win Son, and Ho Foods’ soy milk… www.nytimes.com/2025/10/29/d...

Exactly. This is explicitly building political favoritism into the FDA review process.

The title of this @nejm.org perspective could have been, "Commissioner’s National Priority Voucher Program: The Trumpification of FDA Drug Review." Another must-read from @portalresearch.org www.nejm.org/doi/10.1056/...

Josh Hawley voted for historic cuts to SNAP, which is indispensable to 42 million Americans' food security.

"We would regard it as a positive step if oncologists were discouraged from accepting personal payments from Pharma." 💯 Let's stop pretending industry COI is a good thing! Must-read commentary from Ian Tannock, Saroj Niraula in @ascocancer.bsky.social JCO-OP. ascopubs.org/doi/full/10....

I'll be presenting our new findings at @ascocancer.bsky.social Quality this weekend! I was surprised to find an apparent lack of association between private equity ownership and low-value (but high-profit) cancer care: meetings.asco.org/abstracts-pr... @reshmagar.bsky.social

I'll be presenting our new findings at @ascocancer.bsky.social Quality this weekend! We found substantial health system-level variation in the appropriate use of bone agents to prevent fractures in prostate cancer: meetings.asco.org/abstracts-pr... @mjmorrismd.bsky.social

New: Broad support across the political spectrum for extending enhanced ACA premium tax credits.